Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
R&D's Sprint, IND's Imprint!
Explore DeepSeq.AI - revolutionizing protein screening and drug design with cutting-edge AI. We empower researchers to accelerate discoveries and transform healthcare.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
April 2026 – November 2026 · 3 captures · latest observed messagingMore data. Fewer surprises.
Building the world’s largest atlas of engineered protein interaction data. DeepSeq’s Function-First platform maps live-cell PPI physics to engineer drugs that go beyond simple binder prediction.
21 April 2026 · More data. Fewer surprises.archived page
24 July 2026 · More data. Fewer surprises.archived page
5 November 2026 · More data. Fewer surprises.current websiteHistorical capture not publicly available
January 2025 – January 2026 · 3 capturesMaking the Impossible Possible
Explore DeepSeq.AI - revolutionizing protein screening and drug design with cutting-edge AI. We empower researchers to accelerate discoveries and transform healthcare.
14 January 2025 · Making the Impossible Possiblearchived page
8 July 2025 · Making the Impossible Possiblearchived page
4 January 2026 · Making the Impossible Possiblearchived page
September 2023 – July 2024 · 3 capturesR&D's Sprint, IND's Imprint!
Explore DeepSeq.AI - revolutionizing protein screening and drug design with cutting-edge AI. We empower researchers to accelerate discoveries and transform healthcare.